Partner | | +1 (310) 801-9726

Josh brings more than 20 years of transfer pricing and valuation experience in Big 4, boutique, and in-house roles. Prior to joining Valentiam, Josh spent nearly seven years leading the in-house transfer pricing team at Amgen, a Fortune 500 biotech company.

Josh is a life sciences industry thought leader and has extensive experience advising clients in a range of industries. While leading Amgen’s transfer pricing team, he shaped and oversaw implementation of transfer pricing strategies, policies, and processes, managed operational transfer pricing for tax provision and accounting, led transfer pricing aspects of due diligence and integration for business and product acquisitions, and partnered with leaders across functions to operationalize transfer pricing guidance and support key business decisions.

Josh frequently publishes articles and speaks at industry conferences on transfer pricing and valuation matters. 

Josh Website Photo Round 2


Do you have questions about how we can help you?
Are you looking for expert valuation services or guidance from an experienced transfer pricing group?

Fill out the form below and one of our advisors will get in touch with you shortly.